STAT3 and hepatocellular carcinoma: IL-6, a regulator of NF-κB, can influence hepatocellular carcinoma progression by activating Stat3 [142]. Interestingly, it was found that the core mechanism of DHA’s anti-melanoma cell lung metastasis was related to the STAT3/NF-κB signaling pathway.